Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1058-1062

  Latil, Alain ^a   Cussenot, Olivier ^b   Fournier, Georges ^c   Driouch, Keltouma ^a   Lidereau, Rosette ^a,d  

^a CENTRE RENÉ HUGUENIN   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d Inst Natl de la S et de la R   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 16Q; CONTROLLED STUDY; GENE REPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ALLELES; CADHERINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; SEQUENCE DELETION;

EID: 0030995091     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
2. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi, M., Fujiwara, Y., Kiprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
3. Latil, A., Baron, J-C., Cussenot, O., Fournier, G., Soussi, T., Boccon-Gibod, L., Leduc, A., Rouëssé, J., and Lidereau, R. Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome 18q. Genes Chromosomes Cancer, 11: 119-125, 1994.
4. Zenklusen, J. C., Thompson, J. C., Troncoso, P., Kagan, J., and Conti, C. J. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res., 54: 6370-6373, 1994.
5. Gao, X., Zacharek, A., Salkowski, A., Grignon, D. J., Sakr, W., Porter, A. T., and Honn, K. V. Loss of heterozygosity of BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res., 55: 1002-1005, 1995.
6. Cooney, K. A., Wetzel, J. C., Merajver, S. D., Macoska, J. A., Singleton, T. P., and Wojno, K. J. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res., 56: 1142-1145, 1996.
7. Ittman, M. Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res., 56: 2143-2147, 1996.
8. Kunimi, K., Bergerheim, U., Larsson, I-L., Ekman, P., and Collins, V. P. Allelotyping of human prostatic adenocarcinoma. Genomics, 11: 530-536, 1991.
9. Phillips, S. M. A., Morton, D. G., Lee, S. J., Wallace, D. M. A., and Neoptolemos, J. P. Loss of heterozygosity of retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br. J. Urol., 73: 390-395, 1994.
10. Don on-Bonnet, F., Mautalen, S., Hostein, I., and Longy, M. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer, 14: 171-181, 1995.
11. Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T., and Hirohashi, S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 6791-6794, 1990.
12. Sato, T., Akiyama, F., Sakamoto, G., Kasumi, F., and Nakamura, Y. Allelotype of human ovarian cancer. Cancer Res., 51: 5118-5121, 1994.
13. Maw, M. A., Grundy, P. E., Millow, L. J., Eccles, M. R., Dunn, R. S., Smith, P. J., Feinberg, A. P., Law, D. J., Paterson, M. C., Telzerow, P. E., Callen, D. F., Thomson, A. D., Richards, R. I., and Reeve, A. E. A third Wilms' tumor locus on 16q. Cancer Res., 52: 3094-3098, 1992.
14. Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakers, M. J. G., van Bokhoven, A., and van Roy, F. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics, 26: 281-289, 1995.
15. Vleminckx, K., Vakaet, L., Marcel, M., Fiers, W., and Van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
16. Umbas, R., Isaacs, W. B., Bringier, P. P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne, F. M. J., and Schalken, J. A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929-3933, 1994.
17. Cher, M. L., Ito, T., Weidner, N., Carroll, P. R., and Jensen, R. H. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J. Urol., 153: 249-254, 1995.
18. Mellinger, G. T., Gleason, D., and Bailar, J., III. The histology and prognosis of prostatic cancer. J. Urol., 97: 331-337, 1967.
19. Schroder, F. H., Hermanek, P., Denis, L., Fair, W. R, Gospodarowicz, M. K., and Pavone-Macaluso, M. The TNM classification of prostate cancer. Prostate Suppl., 4: 129-138, 1992.
20. Dogett, N. A., Goodwin, L. A., Tesmer, J. G., Meincke, L. J., Bruce, D. C., Clark, L. M., Altherr, M. R., Ford, A. A., Chi, H. C., Marrone, B. L., Longmire, J. L., Lane, S. A., Whitmore, S. A., Lowenstein, M. G., Sutherland, R. D., Mundt, M. O., Knill, E. H., Bruno, W. J., Macken, C. A., Torney, D. C., Wu, J. R., Griffith, J., Sutherland, G. R., Deaven, L. L., Callen, D. F., and Moysis, R. K. An integrated physical map of human chromosome 16. Nature (Lond.), 377 (Suppl.): 335-366, 1995.
21. Kozman, H. M., Keith, T. P., Donnis-Keller, H., White, R. L., Weissenbach, J., Dean, M., Vergnaud, G., Kidd, K., Gusella, J., Royle, N. J., Sutherland, G. R., and Mulley, J. C. The CEPH consortium linkage map of human chromosome 16. Genomics, 25: 44-58, 1995.
22. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5.264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
23. Weber, J. L., and May, P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet., 44: 388-396, 1989.
24. McGrogan, D., Levy, A., Bostwick, D., Wagner, M., Wells, D., and Bookstein, R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer, 10: 151-159, 1994.
25. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422, 1994.
26. Hudson, T. J., Engelstein, M., Lee, M. K., Ho, E. C. Rubenfield, M. J., Adams, C. P., Housman, D. E., and Dracopoli, N. C. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics, 13: 622-629, 1992.
27. Watanabe, M., Imai, H., Shiraishi, T., Shimazaki, J., Kotate, T., and Yatani, R. Microsatellite instability in human prostate cancer. Br. J. Cancer, 72: 562-564, 1995.
28. Cleton-Jansen, A-M., Moerland, E. W., Kuipers-Dijkshoorn, N. J. K., Gallen, D. F., Sutherland, G. R., Hansen, B., Devilee, P., and Cornelisse, C. J. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer, 9: 101-105, 1994.
29. Kokalj-Vokac, N., Alemeida, A., Gerbault-Seureau, M., Malfoy, B., and Dutrillaux, B. Two color FISH characterization of i (1q) and der (1;16) in human breast cancer cells. Genes Chromosomes Cancer, 7: 8-14, 1993.
30. Alers, J. C., Krijtenburg, P. J., Vissers, K. J., Bosman, F. T. van der Kwast, T. H., and van Dekken, H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 Adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer, 12: 241-250, 1995.
31. Lundgren, R., Mandahl, N., Heim, S., Limon, J., Henrikson, H., and Mitelman, F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer. 4: 16-24, 1992.
32. Micale, M. A., Mohamed, A., Sakr, W., Powell, I. J., and Wolman, S. Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Cancer Genet. Cytogenet., 61: 165-173, 1992.
33. Korsmeyer, S. J. Programmed cell death: Bcl-2. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in oncology, pp. 19-28. Philadelphia: J. B. Lippincott Co., 1993.
34. Callen, D. F., Hildebrand, C. E., and Reeders, S. T. Repport of the second international workshop on human chromosome 16 mapping. Cytogenet. Cell Genet., 60: 158-167, 1992.
35. Tsuda, H., Callen, D. F., Fukutomi, T., Nakamura, Y., and Hirohashi, S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res., 54: 513-517, 1994.
36. Pullman, W. E., and Bordmer, W. F. Cloning and characterization of a gene that regulates cell adhesion. Nature (Lond.), 356: 529-532, 1992.
37. Adams, S. M., Helps, N. R., Brammar, W. J., Walker, R. A., and Varley, J. M. Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumors. Hum. Mol. Genet., 1: 91-96, 1992.
38. Kaupmann, K., Becker-Follmann, J., Scherer, G., Jockusch, H., and Starzinski-Powitz, A. The gene for the cell adhesion molecule M-cadherin maps to mouse chromosome 8 and human chromosome 16q24.1-qter and is near the E-cadherin (Uvomorulin) locus in both species. Genomics, 14: 488-490, 1992.
39. Lee, S. W. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med., 2: 776-782, 1996.
40. Becker, K-F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Seiwert, J. R., and Höfler, H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54: 3845-3852, 1995.
41. Graff, J., Herman, J., Lapidus, R., Chopra, H., Xu, R., Jarrard, D., Isaacs, W., Pitha, P., Davidson, N., and Baylin, S. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55: 5195-5199, 1995.
42. Veronese, M. L., Bullrich, F., Negrini, M., and Croce, C. M. The t(6;16) (p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene. Cancer Res., 56: 728-732, 1996.
43. Liu, P., Tarle, S. A., Hajra, A., Claxton, D. F., Mariton, P., Freedman, M., Siciliano, M. J., and Collins, F. S. Fusion between transcription factor CBF β/PEBP2 β and a myosin heavy chain in acute myeloid leukemia. Science, 267: 1041-1044, 1993.
44. Bussemakers, M. J., van Bokhoven, A., Voller, M., Smit, F. P., and Schalken, J. A. The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome. Biochem. Biophys. Res. Commun., 203: 1291-1294, 1994.
45. Sakr, W. A., Macoska, J. A., Benson, P., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Crissman, J. D. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res., 54: 3273-3277, 1994.
46. Sato, T., Akiyama, F., Sakamoto, G., Kazumi, F., and Nakamura, Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res., 51: 5794-5799, 1991.
47. Latil, A., Fournier, G., Cussenot, O., and Lidereau, R. Differential chromosome allelic imbalance in the progression of human prostate cancer. J. Urol., 156: 2079-2083, 1996.